$0.90
+
$0.02 (2.27%)
End-of-day quote: 05/31/2024
NasdaqCM:CTSO
Cytosorbents Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$36.35M | $34.69M | $40.11M | $41.00M | $24.95M | $22.50M | $15.15M | $9.53M | $4.79M | $4.12M | $2.42M | $1.34M | |
| GM % | Gross Margin % |
|
61.60% | 59.77% | 29.06% | 73.05% | 70.48% | 66.72% | 63.58% | 58.50% | 53.82% | 48.24% | 21.10% | 76.22% | |
| OM | Operating Margin |
|
-83.28% | -90.87% | -0.94% | -25.29% | -76.05% | -69.25% | -64.96% | -120.62% | -194.17% | -167.19% | -194.55% | -259.94% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.64 | $-0.75 | $-0.57 | $-0.20 | $-0.60 | $-0.56 | $-0.32 | $-0.47 | $-0.33 | $-1.29 | $-0.75 | $-0.75 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
54.24m | 43.64m | -220.62m | 43.22m | 32.62m | 31.77m | 28.97m | 25.48m | 25.4m | 23.3m | 10.05m | 8.6m | |
| OCF | Operating Cash Flow |
|
$-21.66M | $-28.23M | $-19290725.00M | $-5.61M | $-16.76M | $-10.84M | $-6.46M | $-6.73M | $-9.05M | $-6.28M | $-3.49M | $-3.62M | |
| FCF | Free Cash Flow |
|
$-18.54M | $-34.32M | $-22931973.00M | $-6.32M | $-18.28M | $-12.36M | $-7.45M | $-6.87M | $-9.45M | $-6.81M | $-3.53M | $-3.64M | |
| FCFS | Free Cash Flow Per Share |
|
$-0.51 | $-0.80 | $-0.42 | $-0.19 | $-0.57 | $-0.40 | $-0.29 | $-0.29 | $-0.39 | $-0.46 | $-0.39 | $-0.46 |
